Lunai Bioworks Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Lunai Bioworks Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- LNAI
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001527728
Board of directors
-
Avram Miller · DirectorSince 2023
-
Carol L. Brosgart · DirectorSince 2023
-
David Hershel Weinstein · Director · Chief Executive OfficerSince 2024
-
Douglas W. Calder · DirectorSince 2024
-
Gregg H. Alton · DirectorSince 2023
-
Henrik Gronfeldt-Sorensen · DirectorSince 2023
-
James A. Mcnulty · DirectorSince 2024
-
James Sapirstein · DirectorSince 2023
-
Jayne McNicol · DirectorSince 2023
-
Karen Brink · DirectorSince 2022
-
Leni Boeren · DirectorSince 2023
-
Mark Anthony Collins · DirectorSince 2024
-
Mark Dybul · Director · Chief Executive OfficerSince 2024
-
Rene Sindlev · DirectorSince 2023
-
Ruud Hendriks · DirectorSince 2023
-
Tilburg Maurice Van · DirectorSince 2024
Chief executives
David Hershel Weinstein
· Chief Executive Officer
Since October 2024
Mark Dybul
· Chief Executive Officer
Until October 2024
· Former
Board connections
5 of this board's directors also sit on 7 other boards.
- via Leni Boeren
- via Gregg H. Alton
- via Carol L. Brosgart
- via James Sapirstein
- via Gregg H. Alton
- via James Sapirstein
- via Douglas W. Calder
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2025 | William Anderson Wittekind 10% owner | Other | −350,000 | — | — |
| Jan 21, 2025 | Tilburg Maurice Van Director | Grant or award | +250,000 | — | — |
| Oct 14, 2024 | David Hershel Weinstein Director, Officer (Chief Executive Officer) | Grant or award | +250,000 | — | — |
| Aug 23, 2024 | Avram Miller Director | Sold back to the company | −833,333 | — | — |
| Aug 12, 2024 | Karen Brink Director, 10% owner | Other | −2,000,000 | — | — |
| Jul 29, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −1,114 | $1.30 | $1,448 |
| Jul 17, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −16,362 | $1.46 | $23,889 |
| Jul 15, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −21,954 | $1.41 | $30,955 |
| Jul 11, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −14,896 | $1.51 | $22,493 |
| Jul 10, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −75,000 | $1.51 | $113,250 |
| Jul 9, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −4,630 | $1.53 | $7,084 |
| Jul 5, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −60,000 | $1.55 | $93,000 |
| Jul 3, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −50,000 | $1.51 | $75,500 |
| Jul 2, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −34,553 | $1.54 | $53,212 |
| Jul 1, 2024 | William Anderson Wittekind 10% owner | Open-market sale | −60,000 | $1.56 | $93,600 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.